Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy

The FEBS Journal
Isamu Okamoto

Abstract

The discovery that signaling by the epidermal growth factor receptor (EGFR) plays a key role in tumorigenesis prompted efforts to target this receptor in anticancer therapy. Two different types of EGFR-targeted therapeutic agents were subsequently developed: mAbs, such as cetuximab and panitumumab, which target the extracellular domain of the receptor, thereby inhibiting ligand-dependent EGFR signal transduction; and small-molecule tyrosine kinase inhibitors, such as gefitinib and erlotinib, which target the intracellular tyrosine kinase domain of the EGFR. Furthermore, recent clinical and laboratory studies have identified molecular markers that have the potential to improve the clinical effectiveness of EGFR-targeted therapies. This minireview summarizes the emerging role of molecular profiling in guiding the clinical use of anti-EGFR therapeutic agents.

References

May 30, 2003·The New England Journal of Medicine·Catherine Roche-LestienneClaude Preudhomme
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Mendelsohn, Jose Baselga
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eunice L KwakDaniel A Haber
Jun 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiko AndoMasahiro Fukuoka
Jun 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueToshihiro Nukiwa
Oct 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heinz-Josef LenzEric K Rowinsky
Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerUNKNOWN IRIS Investigators
Mar 21, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Noriaki SunagaMasatomo Mori
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kimihide YoshidaToyoaki Hida
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro
Mar 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael G AmadoDavid D Chang
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistThomas J Lynch
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Nov 11, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kenji SugioKosei Yasumoto
Jan 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio JimenoS Gail Eckhardt
Jun 18, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Satoshi MoritaToshihiro Nukiwa

❮ Previous
Next ❯

Citations

Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Canhui Guo, George R Stark
Aug 29, 2012·QJM : Monthly Journal of the Association of Physicians·Nicola MumoliJosè Vitale
May 28, 2013·Genome Génome / Conseil National De Recherches Canada·Howard WongRandal N Johnston
Sep 29, 2011·The Oncologist·Dionysis Papadatos-PastosStanley B Kaye
Aug 21, 2012·Biologics : Targets & Therapy·Nitin PatilHeike Allgayer
Jul 13, 2012·Current Oncology·M D VincentS Kamel-Reid
Dec 25, 2013·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Jingjuan QiaoJenny J Yang
Feb 28, 2013·Therapeutic Delivery·Neelesh Kumar MehraNarendra K Jain
Jul 1, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Junko TanizakiKazuhiko Nakagawa
Jul 22, 2015·Proceedings of the National Academy of Sciences of the United States of America·Sarmishtha DeGeorge R Stark
Aug 19, 2010·American Journal of Clinical Pathology·Jeffrey S RossDavid M Jones
Jul 7, 2011·Clinical Colorectal Cancer·Leticia De Mattos-ArrudaJosep Tabernero
Nov 26, 2010·Antiviral Research·Stefan LanghammerHeinz Ellerbrok
Sep 11, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Isamu OkamotoNobuyuki Yamamoto
Mar 17, 2015·Biochimica Et Biophysica Acta·Hirotaka YamashitaKatsumi Matsuzaki
Apr 1, 2012·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·John J Haddad
May 21, 2011·Biochemical and Biophysical Research Communications·Steven M D'AmbrosioHaiming Ding
Aug 24, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Damian KaniowskiBarbara Nawrot
Dec 26, 2018·Expert Review of Anticancer Therapy·Iacopo PanareseRenato Franco
Mar 21, 2019·The FEBS Journal·Christina Plattner, Hubert Hackl
May 8, 2020·Analytical Cellular Pathology (Amsterdam)·Didier MeseureIvan Bieche
Nov 25, 2020·Journal of Cellular Physiology·Bahareh KashaniSeyed H Ghaffari
May 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian P PollackTodd V Cartee
Jul 24, 2020·Anti-cancer Agents in Medicinal Chemistry·Gurubasavaraja S P MatadaGiles Devasahayam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.